Started: 3/2020

Study name: A phase 3, randomized, double- or observer-blinded, placebo-controlled trial to evaluate the efficacy and safety of a respiratory syncytial virus (rsv) perfusion subunit vaccine in infants born to women vaccinated during pregnancy

Indication: RSV/OB

Principal Investigator: Brad Brabec